Arphra
live
S&P 5000.32
NASDAQ0.00
DOW49,602.49
VIX18.06
US10Y4.47
EUR/USD1.1520
GOLD4,353.9
WTI92.63
BTC63,172.79
S&P 5000.32
NASDAQ0.00
DOW49,602.49
VIX18.06
US10Y4.47
EUR/USD1.1520
GOLD4,353.9
WTI92.63
BTC63,172.79

PETS

PetMed Express, Inc.
HealthcareMedical - PharmaceuticalsUSUSDPeers →
$1.68
LiveJun 05, 2026
AI Brief
Market cap
$35.89M
52w range
1.57 – 4.32
P / E
EPS · FY 2026
$-2.74
Volume
570.92K
Revenue · FY 2026
$179.02M

Explain this page

Arphra AI
Business description
· company · SEC profile

PetMed Express, Inc.

PetMed Express, Inc., together with its subsidiaries, operates as a pet pharmacy in the United States. The company markets prescription and non-prescription pet medications, health products, and other supplies for dogs, cats, and horses. It offers non-prescription medications and supplies, such as flea and tick control products, bone and joint care products, vitamins, treats, nutritional supplements, hygiene products, and supplies; and prescription medications, including heartworm preventatives, flea and tick preventatives, arthritis, dermatitis, thyroid, diabetes, pain medications, heart/blood pressure, and other specialty medications, as well as generic substitutes. The company also sells food, beds, crates, stairs, and other pet supplies. It sells its products through its Internet website; mobile app; telephone contact center; and direct mail/print, which includes brochures and postcards, as well as television advertising under the 1-800-PetMeds and PetMeds brands. PetMed Express, Inc. was incorporated in 1996 and is headquartered in Delray Beach, Florida.

Founded
IPO
Apr 26, 1999
Employees
287
HQ
Delray Beach, FL
CEO
Leslie C. G. Campbell
CFO
Exchange
NASDAQ
Fiscal year
Identifiers
· company_identifiers
CIK0001040130
CUSIP716382106
ISINUS7163821066
FIGIPETS US
LEI